Usefulness of selective neutrophil elastase inhibitor, sivelestat, in ALI patients with SIRS
S. Miyoshi, R. Ito, H. Katayama, K. Irifune, H. Hamada, T. Suwaki, N. Nakanishi, T. Kanematsu, K. Dote, M. Aibiki, J. Higaki (Toon, Hiroshima, Niihama, Matsuyama, Japan)
Source: Annual Congress 2012 - How to use technology to provide better critical care
Session: How to use technology to provide better critical care
Session type: Oral Presentation
Number: 395
Disease area: Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Miyoshi, R. Ito, H. Katayama, K. Irifune, H. Hamada, T. Suwaki, N. Nakanishi, T. Kanematsu, K. Dote, M. Aibiki, J. Higaki (Toon, Hiroshima, Niihama, Matsuyama, Japan). Usefulness of selective neutrophil elastase inhibitor, sivelestat, in ALI patients with SIRS. Eur Respir J 2012; 40: Suppl. 56, 395
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013
A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012
Effect of neutrophil elastase inhibitor (ONO-5046) and gabexate mesilate on acid-induced lung injury in rats Source: Eur Respir J 2006; 28: Suppl. 50, 660s Year: 2006
Elevation of neutrophil collagenase (MMP-8) and elastase during COPD exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008
The feasibility of neutrophil elastase inhibitor in the treatment of acute lung injury of post pneumonectomy patients Source: Annual Congress 2010 - Acute respiratory failure Year: 2010
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation Source: Eur Respir J 2003; 22: 739-742 Year: 2003
Inhibition of neutrophil elastase contributes to attenuationof lipopolysaccharide-induced acute lung injuryduring neutropenia recovery in mice Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017
Neutrophil elastase and IL-8 assessment in patients with COPD and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Human neutrophil elastase in acute bronchiolitis Source: Eur Respir J 2004; 24: Suppl. 48, 24s Year: 2004
Pentoxifylline inhibits the neutrophil alveolitis in a murine ARDS model Source: Eur Respir J 2001; 18: Suppl. 33, 238s Year: 2001
Increased intraalveolar levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with interstitial lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 586s Year: 2002
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021
Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
Predictive role of neutrophil elastase in the follow-up of patients with interstitial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
Prophylactic neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning Year: 2014
Antithrombin plus alpha–1 protease inhibitor does not affect pulmonary inflammation and coagulation in a ‘double-hit’ lung injury model Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018
Role of thrombin-activatable fibrinolysis inhibitor in lipopolysaccharide-induced acute lung injury Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
CINC-1 concentration and neutrophil elastase activity are increased in rat ventilator-induced lung injury Source: Eur Respir J 2003; 22: Suppl. 45, 460s Year: 2003